3
Announcements
Trials
Browse
Landscape
Phase
Phase EARLY_PHASE1
1
Phase 3
1
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Cardiotoxicity
2
Breast Neoplasms
2
Ventricular Dysfunction
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Multiple Myeloma
1
Lymphoma
1
Leukemia, Myeloid, Acute
1
Heart Failure
1
Brain Neoplasms
1
Interventions
Cyclophosphamide
60
Vincristine
57
Doxorubicin
54
Rituximab
48
Prednisone
44
Etoposide
35
Radiotherapy
34
Cytarabine
26
Filgrastim
22
Methotrexate
21
Bleomycin
21
Dexamethasone
18
Peripheral Blood Stem Cell Transplantation
14
Carmustine
14
Vinblastine
13
Prednisolone
13
VAP-cyclo protocol
12
Melphalan
12
Mitoxantrone
11
Mercaptopurine
10
Leucovorin
10
Dacarbazine
9
Ifosfamide
8
Granulocyte Colony-Stimulating Factor
8
Procarbazine
7
Methylprednisolone
7
Lenalidomide
7
Gemcitabine
7
Daunorubicin
7
Cisplatin
7
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Lymphoma
×
Carvedilol
×
Clear all
NCT01110824
2013-11-15
OVERCOME
Hospital Clinic of Barcelona
Phase 3
Completed
90 enrolled